Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SPDR S&P Biotech ETF (XBI)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
76.54+2.27 (+3.06%)
At close: 04:00PM EDT
76.65 +0.11 (+0.14%)
After hours: 05:10PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Previous Close74.27
Open74.37
Bid76.54 x 1100
Ask76.65 x 1200
Day's Range73.70 - 76.70
52 Week Range61.78 - 138.60
Volume13,324,808
Avg. Volume15,253,652
Net Assets5.73B
NAV68.67
PE Ratio (TTM)N/A
Yield0.23%
YTD Daily Total Return-41.92%
Beta (5Y Monthly)1.20
Expense Ratio (net)0.35%
Inception Date2006-01-31
  • Barrons.com

    Biotech Stocks Finally Rose in June. What Does It Mean?

    The (ticker: XBI), which tracks small- and mid-cap biotech stocks, fell 33.7% in the first half of the year, which ended on Thursday. The (IBB), which tracks larger biotech names, fell 22.8%. In a note out early Friday, analysts with Cowen biotechnology team noted that June represented the XBI’s first positive month since last August.

  • Barrons.com

    Cryptocurrencies Are Down, But Don’t Count Them Out, Strategist Says

    A bear market has left Bitcoin and the S&P 500 at levels last seen in late 2020. Neither is going out of business anytime soon. Plus, investment newsletter commentary on commodities’ surprising slump, markets and midterms, and falling earnings estimates.

  • ETF.com

    Stocks Fall Into Bear Market

    The S&P 500 fell more than 20% below its all-time high on Monday.

Advertisement
Advertisement